Top Companies in Vascular Access Devices Market

The vascular access device market is projected to reach USD 8.68 billion by 2031 from USD 6.27 billion in 2026, at a CAGR of 6.7% from 2026 to 2031.

The market for vascular access devices is expected to expand due to the rise of chronic diseases like cancer, renal failure, cardiac disorders, and diabetes, which require long-term treatment with intravenous therapy, hemodialysis, chemotherapy, or parenteral nutrition. More hospitals, less invasive procedures, and the growing aging population—who need vascular access several times—are all contributing to the increased demand. The introduction of new technologies such as antimicrobial-coated catheters, ultrasound-guided insertion techniques, and safety-engineered devices to prevent needlestick injuries and catheter-related bloodstream infections is not only improving clinical outcomes but also increasing the adoption rates. Additionally, outpatient care, home-based infusion therapy, and ambulatory surgical centers are on the rise, and the healthcare infrastructure in emerging economies is improving, which together significantly contribute to market growth.

To know about the assumptions considered for the study download the pdf brochure

Some of the prominent players in the market include Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), HealthLine Medical Products (US), Cook Medical (US), and Access Vascular, Inc. (US).

Becton, Dickinson and Company (US)

Becton, Dickinson and Company (BD) has a huge impact on the global market for vascular access devices, and its strong position is due to its wide-ranging and diversified product portfolio that includes peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters, dialysis catheters, and implantable ports. Besides accessories, BD has been selling all these products through its BD Medical and BD Interventional segments through its extensive global distribution network in more than 60 countries. The market strength of BD was greatly enhanced by the strategic acquisition of C.R. Bard in 2017, which not only increased the company's portfolio but also solidified its leadership in multiple vascular access categories.

Teleflex, Incorporated (US)

Teleflex, Incorporated is considered a prominent company in the vascular access device market, bringing a wide range of products like central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, and other vascular access devices under its Arrow brand. All products are directed toward enhancing clinical results and supporting safe, efficient intravenous therapy. The company's strong focus on research and development exemplifies its strategy of continuously launching new products, such as the pressure-injectable Arrowg+ard Blue Plus catheter. Additionally, its expanding global presence in key regions, including Europe, the Middle East, and Africa, has intensified competition in the vascular access segment. Teleflex’s vascular access products have made their way into almost all hospitals and care settings, and the company's strategy to continuously innovate and customize devices based on regional healthcare requirements not only keeps but also strengthens its position as a major player in the market.

ICU Medical, Inc. (US)

ICU Medical, Inc. is a leading global player in the vascular access device market, recognized for its extensive product portfolio and high-quality offerings. Their range includes central venous catheters (CVCs), peripheral IV catheters, needle-free connectors, intraosseous needles, and related accessories, all designed to enhance the safety and efficiency of infusion therapy and vascular access applications.

In 2022, the company expanded its presence and product lineup by acquiring Smiths Medical. This acquisition not only added products in the areas of vascular access, infusion systems, and vital care but also strengthened ICU Medical's position in the global market, including regions such as the Americas, Europe, and the Asia Pacific. ICU Medical places a high value on strict regulatory compliance and product reliability, supported by strong manufacturing standards and extensive clinical support. As a result, the company is poised to maintain its competitive position among the leading firms in the vascular access device industry.

Market Ranking

The vascular access device market is described as having a moderate to high concentration level, where only a few significant global players are contributing a large portion to the total revenues because of their good clinical portfolios, cost-efficient operations, regulatory know-how, and long-standing ties with healthcare institutions. Becton, Dickinson and Company (BD) is among the top market players with its peripheral IV catheters, PICCs, central venous catheters, implantable ports, and advanced needle-free and safety-engineered solutions forming an extensive and diverse vascular access portfolio. Moreover, the merging of Bard’s vascular business, strong scientific proof, and constant invention concerning antimicrobial and clinician safety, all plus its unparalleled global manufacturing and distribution networks, have undoubtedly made BD the leading player in this market.

Another powerful competitor is Teleflex, Incorporated, which is particularly strong in the acute and critical care markets with its Arrow brand offering a wide range of CVCs, PICCs, midlines, and pressure-injectable catheters. Teleflex’s product development prioritizes medical needs over the technologies used. The bacterial-reduction technologies and physician-friendly design, combined with the company's presence in both developed and developing hospital markets, enhance its competitiveness.

ICU Medical is one of the major players in the vascular access device market, whose market position has been further boosted by its acquisition of Smiths Medical. This acquisition has broadened its product portfolio to include peripheral IVs, needle-free connectors, CVCs, and infusion-related vascular access solutions. The company's dedication to patient safety, closed-system technologies, and strong regulatory compliance, along with its expanding global presence, reinforces its role as a major market player.

 Related Reports:

Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com